Clinical study on the necessity and feasibility of routine MRCP in patients with cholecystolithiasis before LC

BMC Gastroenterology

Table 1 Comparison of basic information and preoperative laboratory examination data between the two groups

	Non-MRCP group(n = 83)	MRCP group (n = 101)	T/Z	P
Age (years)	57.33 ± 14.72(mean ± SD) 22–86	60.03 ± 15.61 23–89	-1.200	0.232
Gender
Male	30	48	2.416	0.120
Female	53	53
Height (cm)	165.20 ± 6.79	166.72 ± 7.61	-1.412	0.160
Body weight (kg)	67.44 ± 11.63	69.40 ± 11.81	-1.132	0.259
BMI(kg/m²)	24.67 ± 3.81	24.88 ± 3.28	-0.392	0.695
T(℃)	36.44 ± 0.45	36.42 ± 0.34	0.401	0.689
WBC(*10⁹)	5.66 ± 1.53	5.78 ± 1.72	-0.509	0.612
N%	58.59 ± 10.36	58.90 ± 11.58	-0.192	0.848
ALT(u/L)	28.48 ± 20.86	34.97 ± 31.18	-1.621	0.107
AST(u/L)	26.34 ± 17.63	26.76 ± 20.56	-0.149	0.882
ALP(u/L)	70.25 ± 23.69	76.06 ± 26.29	-1.558	0.121
γ-GT(u/L)	42.83 ± 33.29	46.07 ± 35.30	-0.635	0.526
D-Bil(umol/l)	5.73 ± 3.99	7.11 ± 5.34	-1.956	0.052
I-Bil(umol/l)	8.14 ± 3.53	9.69 ± 4.65	-2.497	0.013
T-Bil(umol/l)	13.87 ± 5.44	16.80 ± 8.14	-2.805	0.006

Note: Normal values for each indicator: T (axillary temperature)37 <°C; WBC 4–10*10⁹/L; N% 50-70%; ALT 7–40 u/L; AST 13–35 u/L; γ-GT 0–50 u/L; ALP 40–110 u/L; D-Bil 0–8 umol/l (or 0-0.47 mg/dL); I-Bil 1–14 umol /l (or 0-0.82 mg/dL); T-Bil 0–23 umol/l (or 0-1.35 mg/dL)

ISSN: 1471-230X